H‐FLAG enabled robust and specific activation of FLAG‐CAR 4 T cells against HER2+ tumor cells, resulting in potent cytotoxicity (Figure 7b) and IFN‐γ secretion (Figure 7c), only when both the HER2‐scFv‐FLAG and tumor antigen were present. Here, ERBB2 is linked to neoplasm.